In conclusion, PYCR2 knockdown suppressed cell proliferation, migration, and invasion via inhibiting the activation of the PI3K/AKT/mTOR pathway in CRC cells, thus providing a potential novel therapeutic target for the diagnosis and treatment of CRC. Here, MTOR is linked to colorectal carcinoma.